Unity Biotechnology, Inc. Assets, Fair Value Disclosure
Unity Biotechnology, Inc. had Assets, Fair Value Disclosure of $42.98 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2023-11-13
- 2023-09-30: Assets, Fair Value Disclosure $42.98M.
- 2022-12-31: Assets, Fair Value Disclosure $87.14M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $42.98M 10-Q · filed 2023-11-13 |
| 2022-12-31 | $87.14M 10-Q · filed 2023-11-13 |